Series B - Panacela Labs
Investment Firm
Overview
Panacela Labs is a clinical-stage biotechnology company focusing on oncology and orphan drug development.
Announced Date
Dec 24, 2015
Funding Type
Series B
Highlights
N/A
Location
N/A
Social
N/A
Investor Lead
N/A
Participant Investors
2
| Investor Name |
|---|
 RUSNANO |
Round Details and Background
Panacela Labs raised $2902600 on 2015-12-24 in Series B
Panacela Labs is a clinical-stage biotechnology company focusing on oncology and orphan drug development.
Company Funding History
2
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Dec 24, 2015 | 2 | - | 2.9M | |
| Oct 07, 2011 | 2 | - | 37.0M |
Recent Activity
There is no recent news or activity for this profile.